SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-037927
Filing Date
2023-11-08
Accepted
2023-11-08 17:06:18
Documents
95
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20230930.htm   iXBRL 10-Q 2107466
2 EX-31.1 dna-20230930xex311.htm EX-31.1 11888
3 EX-31.2 dna-20230930xex312.htm EX-31.2 11837
4 EX-32.1 dna-20230930xex321.htm EX-32.1 5761
5 EX-32.2 dna-20230930xex322.htm EX-32.2 5856
  Complete submission text file 0001628280-23-037927.txt   10960729

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20230930.xsd EX-101.SCH 65714
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20230930_cal.xml EX-101.CAL 81034
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20230930_def.xml EX-101.DEF 514990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20230930_lab.xml EX-101.LAB 837618
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20230930_pre.xml EX-101.PRE 643112
89 EXTRACTED XBRL INSTANCE DOCUMENT dna-20230930_htm.xml XML 1756683
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 231389146
SIC: 2836 Biological Products, (No Diagnostic Substances)